Managing the patient undergoing transcatheter aortic valve replacement with ongoing mitral regurgitation.

导出 LinkOut

翻译打印收藏纠错

作者： Gabriela,Tirado-Conte ^[1] ; Angela,McInerney ^[1] ; Pilar,Jimenez-Quevedo ^[1] ; Manuel,Carnero ^[2] ; Luis A,Marroquin Donday ^[1] ; Alberto,De Agustin ^[1] ; Guy,Witberg ^[3] ; Eduardo,Pozo ^[4] ; Fabian,Islas ^[1] ; Pedro,Marcos-Alberca ^[1] ; Javier,Cobiella ^[1] ; Ran,Koronowski ^[2] ; Carlos,Macaya ^[3] ; Josep,Rodes-Cabau ^[4] ; Luis,Nombela-Franco ^[1]

作者单位： Department of Cardiology, Unit of Interventional Cardiology, Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain. ^[1] Department of Cardiac Surgery, Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain. ^[2] Department of Cardiology, Rabin Medical Centre, Petach-Tikvav, Israel. ^[3] Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel. ^[4] Quebec Heart and Lung Institute, Laval University, Quebec, Canada. ^[5]

关键词 Aortic stenosis TAVI TAVR mitral regurgitation multivalvular heart disease transcatheter aortic valve replacement

主题词主动脉瓣(Aortic Valve);主动脉瓣狭窄(Aortic Valve Stenosis);人类(Humans);二尖瓣闭锁不全(Mitral Valve Insufficiency);疾病严重程度指数(Severity of Illness Index);治疗结果(Treatment Outcome)

DOI 10.1080/14779072.2021.1955347

PMID 34275408

发布时间 2022-04-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交